MedTrace Logo

A Usability Study of External Neuromodulation With iTEAR100 Generation 2

NCT05304650 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-03-31

No results posted yet for this study

Summary

A Usability Study of External Neuromodulation With iTEAR100 Generation 2. A study which evaluates user ability to train and access the iTEAR100 device in a telehealth environment.

Conditions

  • Dry Eye Syndromes

Interventions

DEVICE

iTEAR100

Controlled Stimulation External Nasal Nerve to stimulate tear production

Sponsors & Collaborators

  • Olympic Ophthalmics, Inc.

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2022-04-30
Completion
2022-06-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05304650 on ClinicalTrials.gov